Trials / Conditions / Unresectable Biliary Tract Carcinoma
Unresectable Biliary Tract Carcinoma
5 registered clinical trials studyying Unresectable Biliary Tract Carcinoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolim NCT06656559 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Bi NCT06749730 | Henan Cancer Hospital | Phase 2 |
| Active Not Recruiting | Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co NCT05564403 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobilia NCT06135896 | National Cancer Center, Korea | Phase 2 |
| Recruiting | Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer NCT07062263 | Tata Memorial Centre | Phase 3 |